Literature DB >> 34480263

Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.

Justin Pickering1, Rachel Wong2, Hani Al-Salami3,4, Virginie Lam1,3, Ryu Takechi5,6.   

Abstract

The evidence shows that individuals with type-1 diabetes mellitus (T1DM) are at greater risk of accelerated cognitive impairment and dementia. Although, to date the mechanisms are largely unknown. An emerging body of literature indicates that dysfunction of cerebral neurovascular network and plasma dyshomeostasis of soluble amyloid-β in association with impaired lipid metabolism are central to the onset and progression of cognitive deficits and dementia. However, the latter has not been extensively considered in T1DM. Therefore, in this review, we summarised the literature concerning altered lipid metabolism and cerebrovascular function in T1DM as an implication for potential pathways leading to cognitive decline and dementia.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  amyloid-beta; cerebrovascular dysfunction; hyperglycemia; type 1 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34480263     DOI: 10.1007/s11095-021-03100-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  75 in total

Review 1.  Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.

Authors:  Francesco Zaccardi; David R Webb; Thomas Yates; Melanie J Davies
Journal:  Postgrad Med J       Date:  2015-11-30       Impact factor: 2.401

Review 2.  Dementia.

Authors:  Seth A Gale; Diler Acar; Kirk R Daffner
Journal:  Am J Med       Date:  2018-02-06       Impact factor: 4.965

Review 3.  Diabetes and cognitive dysfunction.

Authors:  Rory J McCrimmon; Christopher M Ryan; Brian M Frier
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

4.  Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort.

Authors:  A M Jacobson; C M Ryan; P A Cleary; B H Waberski; K Weinger; G Musen; W Dahms
Journal:  Diabetologia       Date:  2010-08-29       Impact factor: 10.122

5.  A longitudinal investigation of cognitive function in children and adolescents with type 1 diabetes mellitus.

Authors:  Brenda A Kirchhoff; Dustin K Jundt; Tasha Doty; Tamara Hershey
Journal:  Pediatr Diabetes       Date:  2016-07-22       Impact factor: 4.866

6.  Clinically Relevant Cognitive Impairment in Middle-Aged Adults With Childhood-Onset Type 1 Diabetes.

Authors:  Karen A Nunley; Caterina Rosano; Christopher M Ryan; J Richard Jennings; Howard J Aizenstein; Janice C Zgibor; Tina Costacou; Robert M Boudreau; Rachel Miller; Trevor J Orchard; Judith A Saxton
Journal:  Diabetes Care       Date:  2015-07-07       Impact factor: 19.112

7.  Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes.

Authors:  Inge M W Verberk; Rosalinde E Slot; Sander C J Verfaillie; Hans Heijst; Niels D Prins; Bart N M van Berckel; Philip Scheltens; Charlotte E Teunissen; Wiesje M van der Flier
Journal:  Ann Neurol       Date:  2018-10-04       Impact factor: 10.422

8.  Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats.

Authors:  Predrag Serbedžija; Douglas N Ishii
Journal:  Indian J Endocrinol Metab       Date:  2012-12

9.  Cognitive function in children with type 1 diabetes: a meta-analysis.

Authors:  Patricia A Gaudieri; Rusan Chen; Tammy F Greer; Clarissa S Holmes
Journal:  Diabetes Care       Date:  2008-09       Impact factor: 19.112

10.  Long-term Glycemic Control and Dementia Risk in Type 1 Diabetes.

Authors:  Mary E Lacy; Paola Gilsanz; Andrew J Karter; Charles P Quesenberry; Mark J Pletcher; Rachel A Whitmer
Journal:  Diabetes Care       Date:  2018-09-04       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.